Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway. - Lv Z; Zhang LS; Aisha A; Wang TH; Cui HY; Tang S; Zhang JH; Chang F; Wu WS; Li LY; Zhang ZS; Chen FM (Frontiers in pharmacology, 2026)